Chronic allograft nephropathy: effect of cyclosporine reduction and addition of mycophenolate mofetil on progression of renal disease

By Weir M.R.   Fink J.C.   Hanes D.S.   Gardner J.   Klassen D.K.   Cangro C.   Schweitzer E.   Bartlett S.T.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1286-1287

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil in ongoing chronic kidney allograft dysfunction

By Senn B.   Rochat P.   Schwarzkopf A.K.   Weinreich T.   Binswanger U.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4075-4076

Elsevier

Access to resources Recommend Favorite

Late conversion to mycophenolate mofetil for chronic deterioration of renal allograft function

By Fritsche L.   Sperschneider H.   Budde K.   Giessing M.   Turk H.   Bohler T.   Schroder K.   Stein G.   Neumayer H.-H.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2229-2229

Elsevier

Access to resources Recommend Favorite

Use of Mycophenolate Mofetil in Patients With Chronic Cyclosporine Nephrotoxicity

By Wombolt D.G.   McCune T.R.   Stewart M.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1194-1194

Elsevier

Access to resources Recommend Favorite

Use of mycophenolate mofetil in liver transplant recipients experiencing renal dysfunction on cyclosporine or tacrolimus-randomized, prospective, multicenter study results

By Hodge E.E.   Reich D.J.   Clavien P.A.   Kim-Schluger L.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1546-1547

Elsevier

Access to resources Recommend Favorite